We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
The current SVRA market cap is 585.75M. The company's latest EPS is USD -0.3959 and P/E is -10.71.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -10.54M | -10.88M | -12.11M | -12.22M | -18.04M |
| Net Income | -10.39M | -10.3M | -10.56M | -11.44M | -16.6M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 257k | 0 | 0 | 0 |
| Operating Income | -79.03M | -49.3M | -41.48M | -38.84M | -60.01M |
| Net Income | -78.17M | -49.62M | -43.01M | -38.15M | -54.7M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 147.76M | 139.78M | 129.36M | 119.83M | 182.07M |
| Total Liabilities | 31.24M | 32M | 31.1M | 32.12M | 35.53M |
| Total Equity | 116.51M | 107.78M | 98.26M | 87.72M | 146.54M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 136.2M | 97.75M | 176.6M | 139.78M | 177.56M |
| Total Liabilities | 34.51M | 33.36M | 32.1M | 32M | 37.19M |
| Total Equity | 101.7M | 64.38M | 144.5M | 107.78M | 140.37M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -25.9M | -34.55M | -12.03M | -22.3M | -35.46M |
| Investing | 111.86M | 52.65M | -6.1M | -7.1M | -63.69M |
| Financing | 86k | 87k | 26k | 130k | 74.89M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -45.12M | -39.84M | -40.08M | -34.55M | -51.06M |
| Investing | 15.74M | 9.05M | -69.46M | 52.65M | -57.12M |
| Financing | 54.91M | 3.69M | 120.81M | 87k | 82.78M |
| Market Cap | 585.75M |
| Price to Earnings Ratio | -10.71 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 22.04 |
| Price to Book Ratio | 4.17 |
| Dividend Yield | - |
| Shares Outstanding | 138.15M |
| Average Volume (1 week) | 852.67k |
| Average Volume (1 Month) | 917.46k |
| 52 Week Change | 136.87% |
| 52 Week High | 5.70 |
| 52 Week Low | 1.72 |
| Spread (Intraday) | 0.08 (1.85%) |
| Company Name | Savara Inc |
| Address |
corporation service company wilmington, delaware 19808 |
| Website | https://savarapharma.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
